effects that promote the survival of new neurons in the hippocampus [3] . However, the endogenous factors that regulate the proliferation of neural progenitor cells in the adult hippocampus need to be further clarified.
Several studies have demonstrated that ghrelin enhances neurogenesis. Initially, ghrelin was shown to increase neurogenesis in the dorsal motor nucleus of vagus [4] , the nucleus of the solitary tract [5] and the rat fetal spinal cord [6] in adult rats. We recently have reported that systemic administration of ghrelin stimulates proliferation of newly generating cells in the hippocampus of adult mice [7] . Moreover, immunoneutralization of ghrelin by using anti-ghrelin antiserum in adult mice reduces proliferation of hippocampal progenitor cells in the SGZ [7] . These findings prompted us to hypothesize that endogenous ghrelin may play an important role in adult hippocampal neurogenesis. Considering that neurogenesis in the DG has been proposed to mediate hippocampal-dependent learning and memory [2] , ghrelin-induced stimulation of neurogenesis in hippocampal progenitor cells may play an important role in the ability of ghrelin to enhance memory performance. Indeed, ghrelin knockout (GKO) mice showed impaired memory performance, which was reversed by peripheral administration of ghrelin [8] . However, it is still unclear whether ghrelin directly regulates adult neurogenesis in the DG of the hippocampus. In addition, it remains to be determined that ghrelin-induced neurogenesis is functionally important in learning and memory.
Therefore, in this study, we investigated the role of endogenous ghrelin in regulating the in vivo proliferation and differentiation of the newly generating cells in the adult hippocampus by using ghrelin-deficient mice. We also examined the effect of ghrelin on behavior of these animals in the Y-maze task and the novel object recognition (NOR) test.
Materials and Methods

Animals
To determine the role of endogenous role of ghrelin in adult hippocampal neurogenesis, we used 8-9 weekold male GKO mice [9] and age-matched wild-type C57BL/6J mice. The animals were housed under controlled environmental conditions (12-h light and 12-h dark) with free access to food and water. They were habituated to the housing conditions for 7-10 days prior to the beginning of the experimental procedures. All experiments were approved by the Kyung Hee University Animal Care Committee and conducted according to the principles and procedures outlined in the Guide for the Care and Use of Laboratory Animals as adopted and promulgated by the U. S. National Institutes of health. All efforts were made to minimize animal suffering and to reduce the number of animals used.
Ghrelin treatment and bromodeoxyuridine (BrdU) injection
Ghrelin (Peptides International, Inc., Louisville, KY) at a dose of 80 µg/kg was used to study its effect on progenitor cell proliferation or differentiation in the adult DG of the hippocampus. This dose of ghrelin was chosen on the basis of our previous study demonstrating its effectiveness on cell proliferation in the DG of adult mice [7] . GKO mice received ghrelin or saline intraperitoneally once daily for 8 consecutive days. The wild-type mice were given saline at corresponding times. BrdU (50 mg/kg; Sigma) was given twice daily at 8-h intervals during the last 3 days of ghrelin treatment, and mice were transcardially perfused 1, 7 or 28 day(s) after the last BrdU injection (for the evaluation of BrdU-labeled cells).
Tissue preparation and immunohistochemistry
Animals were anesthetized with xylazine and ketamine and then perfused transcardially with a freshly prepared solution of 4% paraformaldehyde in phosphate-buffered saline (PBS). The brains were removed and post-fixed overnight in the same fixative before being immersed in a solution of 30% sucrose in PBS. Serial 30-µm-thick coronal tissue sections were cut using a microtome and stored in cryoprotectant (25% ethylene glycol, 25% glycerol, 0.05 M PB; pH 7.4) at -20 °C for later immunohistochemistry procedures.
In order to minimize staining variations, the brain sections from the same experiment were processed for immunohistochemical staining simultaneously. To ensure the detection of BrdU-labeled nuclei, we denatured the DNA before incubation with BrdU antibody because BrdU is incorporated into the DNA. DNA denaturation was performed in the following manner: tissue was incubated in 50% formamide and 2× SSC (1× SSC, 0.3 M NaCl and 0.03 M sodium citrate) for 2 h at 65 °C, rinsed for 15 min in 2× SSC, incubated again for 10 min in 0.1 M boric acid at pH 8.5. Free-floating tissue sections were then incubated overnight at 4 °C with primary antibodies (rat anti-BrdU antibody, 1:1000, Santa Cruz Biotechnology, Inc., Santa Cruz, CA; mouse anti-proliferating cell nuclear antigen (PCNA) antibody, 1:500, DakoCytomation, Denmark; rabbit anti-Ki-67 antibody, 1:1000, Abcam, Cambridge, UK). The sections were incubated with appropriate biotinylated secondary antibody (1:200, Vector Laboratories, Burlingame, CA) and then visualized using the avidin-biotin-peroxidase complex method with diaminobenzidine tetrahydrochloride (DAB) as the chromogen. For immunodetection of BrdU, the DAB-nickel enhancement technique was used. For detection of Ki-67, the sections were incubated with a secondary Cy3-goat anti-rabbit IgG (1:400, Jackson ImmunoResearch, West Grove, PA).
To determine the phenotypes of BrdU-labeled cells, brain sections were processed for BrdU, doublecortin (DCX), neuron-specific nuclear antigen (NeuN), or glial fibrillary acidic protein (GFAP) fluorescent double labeling. Briefly, free-floating brain sections were first pretreated for DNA denaturation as described above, and
Behavioral analysis
The Y-maze is a three-arm maze with equal angles between all arms. The maze floor and walls were constructed from dark opaque polyvinyl plastic. Animals were initially placed within one arm, and the sequence and number of arm entries were recorded manually for each animal over an 8 min period. The percentage of trials in which all three arms were represented, i.e., ABC, CAB, or BCA but not BAB, was recorded as an alternation to estimate of short-term memory. Arms were cleaned between tests to remove odors and residues. The alternation score (%) for each animal was defined as the ratio of the actual number of alternation to the possible number (defined as the total number of arm entries minus two) multiplied by 100 as shown by the following equation: % Alternation = [(Number of alternations)/(Total arm entries -2)] × 100. The number of arm entries was used as an indicator of locomotor activity.
We also measured performance of wild-type and GKO mice on NOR, a type of memory considered to be dependent upon the hippocampus [10, 11] . During the training phase, animals were first allowed to explore two identical objects (A and B) in a test chamber for 5 min. The exploration time for each object was recorded using a video-based Ethovision System (Nodulus, Wageningen, The Netherlands). After a 24-h delay, animals were placed again in the apparatus, where one of the original objects was replaced by a novel one (C), and exploration time was measured again for 5 min.
For the Y-maze task and NOR test, animals were implanted with subcutaneous Alzet osmotic minipumps (DURECT Corporation, Cupertino, CA) delivering either ghrelin (50 µg/kg per day ghrelin dissolved in saline, n=6) or vehicle (n=6) for 28 days. Wild-type mice (n=6) were given saline via minipumps.
Statistical analysis
Data are presented as mean ± SEM. Statistical analysis between groups was performed using 1-way ANOVA and Holm-Sidak method for multiple comparisons using SigmaStat for Windows Version 3.10 (Systat Software, Inc. Point Richmond, CA). P < 0.05 was considered statistically significant.
results
Effect of ghrelin on hippocampal neurogenesis in adult mice
Our previous report [7] demonstrating the proliferathen incubated overnight at 4 °C with rat anti-BrdU antibody (1:1000) and goat anti-DCX (1:1000, Santa Cruz Biotechnology, Inc.), mouse anti-NeuN (1:1000, Millipore, Billerica, MA) or rabbit anti-GFAP (1:1000, DakoCytomation). After washing in 0.1 M PBS, sections were incubated for 1.5 h with fluorescent secondary antibodies: Alexa Fluor 488 goat anti-rat IgG to reveal immunoreactivity of BrdU and Cy3-conjugated affinipure donkey anti-goat IgG, Cy3-conjugated affinipure goat anti-mouse IgG or Cy3-conjugated affinipure goat anti-rabbit IgG (1:400, Jackson ImmunoResearch) to reveal immunoreactivities of DCX, NeuN or GFAP, respectively. Then, the sections were washed in PBS and mounted onto coated glass slides, and coversliped with fluorescent mounting medium.
Quantification and phenotype of newborn cells
The total numbers of BrdU-, PCNA-and Ki-67-labeled cells in mice were manually counted in the right and left SGZ along the superior and inferior blades of the DG of every sixth sections throughout the entire extent of the hippocampus (from Bregma -1.06 mm to Bregma -3.80 mm), using Stereo Investigator (MicroBrightField, Williston, VT). Analysis was performed using a computer-assisted image analysis system consisting of a Zeiss Axioscope-2 microscope equipped with a computer-controlled motorized stage, a video camera, and Stereo Investigator software. Counting was done at 400× magnification using a Zeiss Axioscope-2 microscope equipped with a 40× objective lens. Cells were counted throughout each section by focusing through each focal plane of the section to ensure that all BrdU-labeled cells were visible. For PCNA and Ki-67, only cells with robust nuclear immunoreactivity were considered positive. The resulting numbers from each section were added and multiplied by 6 to obtain the estimated total number of labeled cells per DG for each brain.
Double-labeled cells for BrdU and DCX, NeuN or GFAP were counted using a Carl Zeiss LSM 700 Meta confocal microscope. The extent of colocalization was confirmed by three-dimensional reconstructions (X, Y, and Z) using Z-plane sectioning in order to exclude false double labeling. BrdU single-labeled cells and BrdU/ DCX, BrdU/NeuN or BrdU/GFAP double-labeled cells were counted. The percentage of BrdU cells doublelabeled for DCX, NeuN or GFAP was calculated by dividing the number of double-labeled cells by the total number of BrdU cells and multiplying 100. tive effect of ghrelin and the inhibitory effect of antighrelin antibody on hippocampal progenitor cells in normal adult mice suggests the role of endogenous ghrelin in neurogenesis. To address whether endogenous ghrelin controls proliferation of neural precursor cells, we assessed the number of cycling cells in the DG region of GKO mice and their wild-type controls by using PCNA, a marker for cell proliferation [1] . We detected significantly lower number of newly generating PCNA-labeled cells in GKO mice compared to wild-type controls (Fig. 1A, B) , indicating decreased cell proliferation. To determine whether exogenous ghrelin can alter the number of PCNA-labeled cells in the DG of GKO mice, we assessed this parameter after treatment of GKO mice with ghrelin (80 µg/kg, ip, once daily for 8 consecutive days). This treatment resulted in a shift in the number of newborn cells of GKO animals toward the wild-type values (Fig. 1A, B) . We also examined the changes in the number of Ki-67-labeled cells, another marker for cell proliferation in the brain [12] , and obtained similar results (Fig. 1A, C) .
Consistent with these findings, we found similar changes in the number of BrdU-labeled cells in the DG 1 day after the last BrdU injection (Fig. 1A, D) . In order to ascertain the phenotype of newborn (proliferating) cells labeled by BrdU under these conditions, brain sections were stained with antibodies against both BrdU and the early neuronal marker DCX. Double labeling immunohistochemistry showed co-expression of nuclear BrdU and cytoplasmic DCX in the DG ( Fig.  2A) . One day after the last BrdU injection, the percentage of BrdU/DCX double-labeled cells was significantly reduced in GKO mice (21.7%) compared to wild-type controls (28.4%; Fig. 2B ). However, ghrelin treatment restored the percentage of the BrdU/DCX double-labeled cells of GKO mice to the control values (Fig. 2B) . We also found a similar reduction in the percentage of BrdU-labeled cells co-expressing DCX in GKO mice (46.0%) than in wild-type controls (60.1%) 7 days after the last BrdU administration, which was significantly increased by ghrelin treatment (Fig. 2C) . Next, we determined if ghrelin could affect the fate of newborn cells. The total number of BrdU-labeled cells remained significantly lower in the GKO mice than the wild-type controls 28 days after the last BrdU administration (Fig. 3C) . By contrast, ghrelin treatment resulted in an increase in the number of BrdU-labeled cells toward the wild-type values (Fig. 3C) . The extent of differentiation of survived BrdU-labeled cells was determined by double labeling immunohistochemistry with antibodies against BrdU and NeuN, the neuronal marker, or GFAP, the glial marker (Fig. 3A, B) . Confocal microscopic analysis of colocalization of BrdU with NeuN or GFAP revealed that the majority of BrdU-labeled cells had the neuronal phenotype and a low percentage of BrdU-labeled cells were positive for GFAP (Fig. 3D) . The percentage of BrdU-labeled cells that were double labeled for NeuN was significantly decreased in GKO mice, which was increased to wild-type values when GKO animals were treated with ghrelin (Fig. 3D) . In contrast, the percentage of BrdUand GFAP-labeled cells was not altered either in GKO mice or by ghrelin treatment (Fig. 3D) .
Effect of ghrelin on learning and memory processes in adult mice
To investigate whether endogenous ghrelin plays a physiologic role in hippocampus-dependent spatial working memory performance, animals were tested for spontaneous alternation behavior in a Y-maze. There was no difference in total entry between groups (Fig.  4A) . GKO mice showed significantly reduced alternation rates when compared to wild-type controls (Fig.  4B) . In contrast, ghrelin replacement by subcutaneous The GKO mice showed a significant decrease in alternation behavior, which was reversed by ghrelin administration. C, Exploration time during the first phase. All three groups spent similar amounts of time at each objects (A and B). D, Exploration time during the second phase. GKO mice spent more time exploring the familiar object and less time exploring the novel object when compared to wild-type mice. These differences were abolished by 28 days of ghrelin replacement. The data expressed as the mean ± SEM (n=6/group). * P<0.05 vs. wild-type, † P<0.05 vs. vehicle-treated GKO mice.
osmotic mini-pump for 4 weeks significantly attenuated this impairment (Fig. 4B) . We also measured how GKO mice performed in the NOR test that is used to assess non-spatial memory and relies on the animal's natural tendency to differentially explore novel objects over familiar ones. The NOR is known to depend, in part, on hippocampus [10, 11] . In the first phase of the test, there was no significant difference in total exploration time between groups and all three groups spent similar amounts of time at each object (A or B) (Fig. 4C) . After a 24-h delay, the animals were exposed to two dissimilar objects placed in the same test chamber: one familiar object (A or B) used in the first phase and one novel object (C), and the time spent exploring each of the objects was measured. As shown in Fig. 4D , wild-type animals spent more time exploring the novel object than the familiar one. In contrast, GKO mice showed significantly increased exploration time for familiar object and decreased exploration time for novel one when compared to wildtype animals. These data suggest that GKO mice have impairment in their memory of the previous objects. However, this functional deficiency was disappeared when GKO mice were replaced with ghrelin by subcutaneous osmotic mini-pumps (Fig. 4D) .
Discussion
Over the last decade, numerous studies have demonstrated that ghrelin plays important roles in GH release, food intake, body weight regulation and glucose homeostasis. Besides its importance in energy metabolism, the abundant expression of GHS-R1a in brain regions outside the hypothalamus suggests its significance in neuronal function. Emerging evidence suggests that ghrelin acts in the CNS to control neuronal function and subsequently has a profound influence on various brain functions [13] . In the current study, we provide evidence that endogenous ghrelin regulates adult hippocampal neurogenesis and it is important for ghrelin-induced learning and memory processes. Specifically, ghrelin-deficient mice showed lower numbers of progenitor cells in the DG of the hippocampus, while ghrelin treatment restored progenitor cell numbers to those of wild-type controls. To the best of our knowledge, this is the first report demonstrating reduced adult hippocampal neurogenesis in ghrelin-deficient mice.
Given that peripheral ghrelin can pass through the blood-brain barrier and ghrelin binding sites and receptors are found in the hippocampus [8] strongly suggests that peripherally administered ghrelin enters the hippocampus and directly stimulates neurogenesis within the DG of the hippocampus. Our results also showed that differentiation is affected by ghrelin, because a decrease was seen not only in the number of BrdU-positive cells but also in the fraction of immature neurons and newly generated neurons in the GKO mice, which were increased by ghrelin replacement. Nonetheless, we cannot exclude the possibility that the action of ghrelin could be, in part, due to the ability of ghrelin to stimulate the GH/IGF-1 axis [14] , where both GH and IGF-1 infusions have been shown to increase hippocampal neurogenesis [15, 16] . The ghrelin-associated changes in hippocampal neurogenesis observed in experimental models may indeed be important in learning and memory process. For example, calorie restriction, which is paralleled by elevated circulating ghrelin [17] , is known to be associated with increased adult neurogenesis in young adult rats [18] and enhanced performance of animals in a variety of behavioral tests that are dependent on the hippocampus [19, 20] . In contrast, the development of dementia is more common in the elderly and obese patient [21] , which are known to have reduced ghrelin levels [22, 23] and decreased hippocampal neurogenesis [24, 25] . In the current study, we have shown that targeted disruption of ghrelin resulted in impaired memory performance of mice in the NOR test, which was rapidly reversed by ghrelin administration. Consistent with these findings, Diano et al. have reported that NOR performance was impaired in the GKO mice, which was rescued by peripheral ghrelin replacement via osmotic minipumps [8] . In addition, we also found that the GKO mice exhibited decreased spontaneous alternation behavior in the Y-maze, suggesting impairment in their spatial working memory. However, this functional impairment in the GKO mice was attenuated by ghrelin replacement therapy, indicating this peptide hormone exerts influences on brain structures responsible for learning and memory performance. It is unlikely that the learning impairment observed in the GKO mice could be attributed to decreased general locomotor activity, because there were no differences in total arm entries.
Several lines of evidence indicate that ghrelin plays an important role in learning and memory processes. Specifically, intracerebroventricular or intrahippocam-pal injection of ghrelin increases memory retention in rodents [26, 27] . Ghrelin administered directly into the dorsal raphe nucleus (DRN) also increased memory retention via serotonergic inputs from the DRN [28] . Considering that adult hippocampal neurogenesis is correlated with spatial learning and memory process, decreased neurogenesis in GKO mice may contribute to impaired cognitive function. Indeed, memory impairment in ischemic injury is associated with neuronal cell loss in the hippocampus [29] . Several growth factors, including FGF-2, IGF-1 and VEGF, improve cognitive function through enhancement of generation or survival of new neurons in the hippocampus [3] . Therefore, it is likely that ghrelin-induced stimulation of neurogenesis in hippocampal progenitor cells may play an important role in improving cognitive functions. Another proposed mechanism through which ghrelin might enhance learning and memory is the promotion of hippocampal synaptic plasticity by augmenting dendritic spine formation and long term potentiation [8] .
In summary, we have demonstrated that the absence of ghrelin results in reduced neurogenesis in the DG of adult hippocampus and impaired learning and memory, whereas systemic administration of ghrelin reverses these changes. These findings are significant because our data support the idea that ghrelin-induced hippocampal neurogenesis is required for the actions of ghrelin on hippocampus-related learning and memory processing. Therefore, ghrelin may be a plausible therapeutic approach for impaired cognitive function.
